However, GSK-3 is overexpressed in various cancer conditions such as colon, liver, ovarian, and pancreatic tumors and GSK-3β downregulation inhibits pancreatic cancer growth, angiogenesis, and vascular endothelial growth factor expression [29–32]. Here, GSK3B is linked to cancer.